Observational studyJapanese journal of clinical oncology2022

Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study).

Takahiro Kojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.